Valorant: The Spiders vs Axolotl (BO3) - VCT Game Changers North America Playoffs

90¢

▲ 40.0pp

24h change

vol cum

$0

vol 24h

$0

spread

0.20

ends

Sep 2, 2026

This market refers to the Valorant match between Axolotl and The Spiders in the VCT Game Changers North America Playoffs, initially scheduled for September 1, 2026 at 5:00 PM ET. This market is decided solely by the round score of Map 1 of this match, and is independent of which team wins Map 1 or the overall match. This market will resolve to "Axolotl" if Axolotl wins Map 1 by 3 or more rounds, including any overtime (i.e. Axolotl's round total on Map 1 exceeds The Spiders's by 3 or more). Otherwise, this market will resolve to "The Spiders". Map 1 must be played to completion, with a final round score determined by rounds actually played, for this market to resolve to a team. If Map 1 is completed in this way, the market resolves on that round score regardless of how the remainder of the match concludes (including any later forfeit, disqualification, walkover, or default). If Map 1 is not played at all, is not played to completion, or is decided by forfeit, disqualification, walkover, or default rather than by rounds played to a conclusion, this market will resolve 50-50. If the match is canceled, this market will resolve 50-50. If the match is postponed, it must be rescheduled to a start time on or before September 15, 2026 at 11:59 PM ET (14 calendar days after the originally scheduled start of September 1, 2026 at 5:00 PM ET). If, by that deadline, the most recently announced rescheduled start time is on or before the deadline, this market resolves based on the result of the match as played. Otherwise, this market resolves 50-50, regardless of whether the match is subsequently played. The resolution source for this market will be official information from https://vlr.gg. However, if https://vlr.gg has not published final results within 2 hours after the event's conclusion, a consensus of credible reporting may be used instead, including video evidence.